About Hospital Brigadeiro
Clinical Trials at Hospital Brigadeiro
During the past decade, Hospital Brigadeiro conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Brigadeiro" #1 sponsor was "Novartis Pharmaceuticals" with 2 trials, followed by "Bial - Portela C S.A." with 1 trials
sponsored, "Eisai Inc." with 1 trials sponsored, "Millennium Pharmaceuticals, Inc." with 1 trials sponsored and "National Cancer Institute (NCI)"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Brigadeiro"
#1 collaborator was "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator, "Multicenter Hemophilia Cohort Study" with 1 trials as a collaborator and "Sunovion" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Hospital Brigadeiro
According to Clinical.Site data, the most researched conditions in "Hospital Brigadeiro" are
"Epilepsy" (2 trials), "Epilepsies, Partial" (1 trials), "Hepatocellular Carcinoma" (1 trials), "Liver Decompensation" (1 trials) and "Non-Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "Hospital Brigadeiro" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Brigadeiro
Most popular intervention types in "Hospital Brigadeiro" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "oxcarbazepine" (2 trials), "1200 mg QD Eslicarbazepine acetate" (1 trials), "800 mg QD Eslicarbazepine acetate" (1 trials) and "Bortezomib + Rituximab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Brigadeiro
The vast majority of trials in "Hospital Brigadeiro" are
6 trials for "All" genders.
Clinical Trials Status at Hospital Brigadeiro
Currently, there are NaN active trials in "Hospital Brigadeiro".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Hospital Brigadeiro,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Brigadeiro, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".